(RTTNews) – Astellas Pharma Inc. (ALPMY, ALPMY) announced results from the GATHER2 Phase 3 clinical trial, demonstrating Izervay (avacincaptad pegol intravitreal solution) Read More
Search
Newsletter
Stock Prices
Symbol | Last Price | Change | % Change |
---|---|---|---|
Investing News
- Accountant vs. Controller: What’s the Difference?
- How to Make Money With Real Estate Options
- Who Are Bank of America’s Main Competitors?
- Who Are Bank of America’s Main Competitors?
- TD Bank CD Rates: November 2024
- TD Bank CD Rates: November 2024
- Fidelity CD Rates: November 2024
- Fidelity CD Rates: November 2024
- Average Profit Margin Overview in the Banking Sector
- Average Profit Margin Overview in the Banking Sector